<DOC>
	<DOC>NCT00739297</DOC>
	<brief_summary>This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.</brief_summary>
	<brief_title>The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>A person is 15 to 65 years of age. A person has had chronic asthma for at least one year A person is a smoker or has smoked more that a pack a day for more than 10 years before stopping A person has other lung disorders such as COPD (chronic obstructive pulmonary disorder)</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Chronic asthma</keyword>
</DOC>